Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01730898 · ClinicalTrials.gov registry record · Phase 3
Lutein Absorption in Healthy Adults
A Phase 3 study, sponsored by Abbott Nutrition.
- Completed
- Registry status
- Phase 3
- Development phase
- 24
- Enrollment target
NCT01730898: Completed Phase 3 study, sponsored by Abbott Nutrition.
NCT01730898 is a Phase 3 study that has completed, run by Abbott Nutrition. The registered enrollment target is 24 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01730898, a Phase 3 study, has completed, sponsored by Abbott Nutrition.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 24 participants
- Enrollment target
Study Summary
This study will evaluate the absorption of lutein when consumed in different oil blends.
Primary Outcome
adjusted area under the curve at specified postprandial timepoint
Interventions
- OTHER Study product containing lutein
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2012-11 |
| Est. Completion | 2013-03 |
| Phase | Phase 3 |
What the finished NCT01730898 record still lists
NCT01730898 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 1 intervention - of which Study product containing lutein is the first listed.
NCT01730898 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01730898 about?
NCT01730898 is a clinical study titled "Lutein Absorption in Healthy Adults". This study will evaluate the absorption of lutein when consumed in different oil blends.
What is the current status of trial NCT01730898?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 24 participants. The study started on 2012-11. Estimated completion is 2013-03.
What interventions are being tested in trial NCT01730898?
The interventions under investigation include: Study product containing lutein (OTHER).
Who is sponsoring clinical trial NCT01730898?
This trial is sponsored by Abbott Nutrition, which has 89 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01730898's enrollment target sits among peer trials
24 1943rd of 2000 higher than 49 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia